AsepticSure Efficacy Clarification

AsepticSure SystemHAI reduction rates and pathogen-specific log reductions are two different measurements and should not be confused as being the same.

It appears that there is confusion among some of you around the HAI reduction capacity attributed to Asepticsure. This brief update is intended to clear up any such confusion.

Please note that when we use the term “HAI”, we are referring to “Hospital Acquired Infection”. To reduce the RATE of such infections by 20% – 30% would be an incredible achievement and one that would translate into millions of lives and billions of dollars saved. NOTE: Our goal is to significantly exceed the above-stated reduction rate and we are already on track to achieve this!

When we speak of a “99.9999% kill”, we are referring to the extent to which AsepticSure can reduce the concentration of hospital pathogens which cause HAIs (i.e. a 6 Log reduction is virtual elimination).

Medizone is now looking at ways of integrating AsepticSure into a comprehensive program – one that would involve improved patient and staff education, enhanced day-to-day cleaning procedures and even improved disinfection solutions. Collectively, these enhancements and improvements may very well further reduce the incidence of HAI.

One thing though is very clear – WITHOUT AsepticSure, very little can be achieved that has not already been achieved!

With that in mind, I’d like to clear up a misconception around claims made by a competitor product:

It should be noted that a reported and AsepticSure kills 99.9999% of C.difficilemuch-hyped 67% reduction in C.diff-related HAIs based on such small numbers (i.e. time-limited data) is not convincing and must be understood as only one of a large number of pathogens known to cause such infections in hospital environments.

NOTE: 9 months – as per the reported competitor case study – is a short time for observation by medical research standards, and it is well known that C diff and other infection rates go up and down over many months to years.

Short-term before and after studies such as this do not take into account the fact that there is a significant natural variability in the rates of infections in any institution over time. Such a reduction (as the one reported) is just as likely to have been by chance as by the effect of the room treatment.

To validate this point, here is an example of a hospital that achieved an 80% reduction in C.diff infection rates merely by using best practice hygiene standards without the aid of any additional disinfection technology.

The total picture of HAI for any institution is a composite of many different individual infections including but not limited to C. difficile, MRSA, VRE, Resistant E coli, TB etc. The benchmark set by AsepticSure is its broad spectrum of activity against all of these HAI pathogens, plus the fact that it reaches all surfaces and spaces and achieves such a high level of sustainable bacterial kill (i.e. 6 log bacterial kill). This standard of broad spectrum disinfection is unprecedented.

 

Regards

Dr Michael E. Shannon, President

Contact:

Medizone International, Inc. (MZEI.OB)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Investor Relations:

John Pentony

Investor Relations
Medizone International, Inc.

Telephone: (415) 331-0202

E: j.pentony@medizoneint.com

Media Contact:

Gary Hanauer

Media Relations
Medizone International, Inc.

Telephone: (510) 686-1238

E: GarHan@aol.com